Aeglea BioTherapeutics, Inc.

Historical 13F Holders

Symbol
AGLE
CUSIP
00773J103
All holders as of
Q3 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q3 3 318 k $3.96 M
2023 Q2 46 70.9 M $32.0 M
2023 Q1 46 41.3 M $12.0 M
2022 Q4 55 42.9 M $19.3 M
2022 Q3 57 44.7 M $23.5 M
2022 Q2 69 49.4 M $26.3 M
2022 Q1 87 41.4 M $95.4 M
2021 Q4 91 39.9 M $190 M
2021 Q3 80 40.6 M $322 M
2021 Q2 82 41.5 M $289 M
2021 Q1 87 41.5 M $329 M
2020 Q4 97 42.0 M $331 M
2020 Q3 97 38.8 M $275 M
2020 Q2 88 38.0 M $352 M
2020 Q1 72 20.6 M $95.8 M
2019 Q4 70 21.0 M $160 M
2019 Q3 73 20.1 M $154 M
2019 Q2 79 20.0 M $137 M
2019 Q1 74 20.1 M $162 M
2018 Q4 62 16.6 M $124 M
2018 Q3 63 14.7 M $141 M
2018 Q2 65 14.9 M $157 M
2018 Q1 38 8.48 M $84.1 M
2017 Q4 32 7.92 M $42.9 M
2017 Q3 33 7.80 M $38.1 M
2017 Q2 33 7.91 M $30.4 M
2017 Q1 24 5.17 M $38.5 M
2016 Q4 27 5.61 M $24.4 M
2016 Q3 28 5.93 M $38.0 M
2016 Q2 23 5.53 M $26.6 M